KORU Medical inks deal for Phase 3 trial of SCIg drug

Mar 6, 2024 - 07:30

KORU Medical inks deal for Phase 3 trial of SCIg drug

AMAZON.CA DEALS

AMAZON.CA DEALS

Previous Article

Nordstrom shares target raised by TD Cowen on earnings beat

Thor Industries stock falls 14% on earnings and revenue miss

SHOP AMAZON.CA

SHOP AMAZON.CA

Related Posts

Buyout firm Roark explores sale of Primrose Schools, so...

May 16, 2024

European shares advance on tech, real estate boost; Swi...

Jun 20, 2024

European stocks up ahead of U.S. inflation data

Nov 14, 2023

Earnings call: Affirm Holdings Inc. Q2 2024 results, op...

Feb 9, 2024

Earnings call: Academy Sports + Outdoors sees mixed Q1 ...

Jun 13, 2024

European shares rise on last trading day of the year, s...

Dec 29, 2023

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

TODAY'S DEALS

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

SHOP AMAZON.CA